Researchers at UCLA have developed a molecular compound, kown as a molecular tweezer,  that improves balance and coordination in mice with early stage Parkinson’s disease. Further, the drug, called CLR01, reduced the amount of a toxic protein in the brain that is thought to be one of the prime culprits in the development of the disorder.

Read more at: BioScience Technology

Parkinson’s Community LA